
Novacel Therapeutics Private Limited
About Novacel Therapeutics Private Limited
Data last updated:
Novacel Therapeutics Private Limited is a private limited company based in Guntur, Andhra Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 September 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U33116AP2014PTC095396. Its GSTIN is 36AAFCN4488B1ZF (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Chandrasekhararao Bollu and Dama Hari Prasad.
Its last annual general meeting (AGM) was held on 21 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Door. No. 6 – 21 – 23 10/2 Raj Towers Arundelpet, Guntur, Andhra Pradesh, India – 522002.
As per the financials filed for FY 2020, the company reported a revenue of ₹13.03 Cr, a decline of 27% compared to the previous year. For the same year it recorded a net profit of ₹7.41 Lakh (net margin 0.6%) and EBITDA of ₹11.35 Lakh (EBITDA margin 0.9%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Novacel Therapeutics Private Limited's registered office is in Guntur, Andhra Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressDoor. No. 6 – 21 – 23 10/2 Raj Towers Arundelpet, Guntur, Andhra Pradesh, India – 522002
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Novacel Therapeutics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Novacel Therapeutics is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Novacel Therapeutics Private Limited, buy the company report.
Financials of Novacel Therapeutics Private Limited
FY 2020 filings availableNovacel Therapeutics Private Limited reported revenue of ₹13.03 Cr (down 27% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue fell 27% in the latest year. EBITDA fell 21% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹13.03 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.35 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.41 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.9% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Novacel Therapeutics Private Limited, buy the company report.
Board of directors of Novacel Therapeutics Private Limited
Novacel Therapeutics has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dama Hari Prasad Also directs: Originix Healthcare Private Limited | Additional Director | 14 Apr 2021 | 5 Years 7 Months | Current |
| Chandrasekhararao Bollu | Director | 27 Sep 2014 | 12 Years 1 Months | Current |
Peer comparison
Novacel Therapeutics Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Embee Healthcare Private Limited | ₹13.05 Cr (FY 2024) | -4.0% | New Delhi, Delhi, India | |||
| Aurora Nutraceuticals Private Limited | ₹13.05 Cr (FY 2025) | -2.0% | New Delhi, Delhi, India | |||
| Novacel Therapeutics Private Limitedthis company | ₹13.03 Cr (FY 2020) | ₹7.41 Lakh | 0.6% | -27.0% | Guntur, Andhra Pradesh, India | |
| Elinor Pharmaceuticals Private Limited | ₹12.99 Cr (FY 2024) | -30.0% | Hyderabad, Andhra Pradesh, India | |||
| Novolife Healthcare Private Limited | ₹12.98 Cr (FY 2025) | 10.0% | Hyderpora, Jammu and Kashmir, India | |||
| Good Hope Healthcare Private Limited | ₹12.97 Cr (FY 2025) | 3.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Novacel Therapeutics Private Limited, buy the company report.
Auditor
Novacel Therapeutics Private Limited is audited by NAMBURU & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NAMBURU & ASSOCIATES | FY 2019 | 012714S |
Shareholding
The shareholding of Novacel Therapeutics Private Limited is on record for 4 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Novacel Therapeutics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Novacel Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Novacel Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Novacel Therapeutics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCN4488B1ZF | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Novacel Therapeutics Private Limited, buy the company report.
Recent activity
Novacel Therapeutics Private Limited has 3 board changes on record since 2014: 2 appointments and 1 cessation. The latest: Arepalli Babu Venkata Kishore ceased to be Director on 17 Apr 2021.
Frequently asked questions
Novacel Therapeutics is an active private limited company based in Guntur, Andhra Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 September 2014 (12+ years old) and is registered under CIN U33116AP2014PTC095396.
Novacel Therapeutics has 2 current directors:
- Dama Hari Prasad - Additional Director
- Chandrasekhararao Bollu - Director
The latest financial statements of Novacel Therapeutics on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 21 December 2020. Year-wise statements from 2015 are in the company report.
The GSTIN of Novacel Therapeutics is 36AAFCN4488B1ZF, registered in Telangana.
The CIN (Corporate Identification Number) of Novacel Therapeutics is U33116AP2014PTC095396. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Novacel Therapeutics was incorporated on 27 September 2014, making it 12+ years old. It is registered with the Registrar of Companies, Vijayawada.
The peers of Novacel Therapeutics by revenue are Embee Healthcare Private Limited, Aurora Nutraceuticals Private Limited, Elinor Pharmaceuticals Private Limited, Novolife Healthcare Private Limited, Good Hope Healthcare Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Arepalli Babu Venkata Kishore ceased to be Director on 17 Apr 2021. Dama Hari Prasad was appointed as Additional Director on 14 Apr 2021. Chandrasekhararao Bollu was appointed as Director on 27 Sep 2014.
The registered office of Novacel Therapeutics is at Door. No. 6 – 21 – 23 102 Raj Towers Arundelpet, Guntur, Andhra Pradesh, India – 522002.
Novacel Therapeutics operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Novacel Therapeutics is compliant as of 03 July 2026. The company is actively filing with the Registrar of Companies.

